title: Major response to vemurafenib in patient with severe cutaneous Langerhans cell histiocytosis harboring BRAF V600E mutation.
authors.affiliation: Dermatology Unit, Univ. Grenoble Alpes, IAB, CHU de Grenoble, F-38000 Grenoble, France. Electronic address: Jcharles@chu-grenoble.fr.
authors.forename: Julie
authors.initials: J
authors.lastname: Charles
authors.affiliation: Dermatology Unit, Univ. Grenoble Alpes, IAB, CHU de Grenoble, F-38000 Grenoble, France.
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Beani
authors.affiliation: Department of Pathology, CHU de Grenoble, F-38000 Grenoble, France.
authors.forename: Giacomo
authors.initials: G
authors.lastname: Fiandrino
authors.affiliation: Cancer Clinical Laboratory, Univ. Grenoble Alpes, IAB, CHU de Grenoble, F-38000 Grenoble, France.
authors.forename: Benoit
authors.initials: B
authors.lastname: Busser
mesh_terms: D000369:Aged, 80 and over; D005260:Female; D006646:Histiocytosis, Langerhans-Cell / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000627:therapeutic use*; D009154:Mutation; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use*; D000077484:Vemurafenib
chemical_list: D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; D048493:Proto-Oncogene Proteins B-raf